Dave Muoio

A product image of the existing AncestryHealth offering.

By Dave Muoio 03:15 pm August 24, 2020
Consumer genomics company Ancestry recently received two FDA 510(k)s – one for an in vitro molecular test that detects genomic variants tied to potential disease risk, and another for a saliva-based DNA specimen-collection kit. Both of these submissions were received by the FDA in October of last year, which officially cleared them on August 13, according to the agency's 510(k) database. Each was...
By Dave Muoio 11:49 am August 24, 2020
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds. The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments. Launched in late 2016, One Drop's wireless blood...
By Dave Muoio 02:24 pm August 21, 2020
Exo, a Silicon Valley company known for its in-development handheld ultrasound device, announced $40 million in new funding yesterday. GlaxoSmithKline's Investor Action Potential Venture Capital fund was among the Series B+ round's unnamed investors. Exo said in its announcement that it will be using the funds to wrap up product development for that device, and to bring its data and workflow apps...
By Dave Muoio 03:23 pm August 20, 2020
Picking through the scraps. Following the bankruptcy of 'digital pill' maker Proteus Digital Health, business partner and stakeholder Otsuka Pharmaceutical has been approved to purchase the digital health company's assets by a federal bankruptcy court judge, STAT reports. Otsuka's bid was challenged by Novartis, two former Proteus executives and other investors, who argued that the agreed upon $...
By Dave Muoio 02:21 pm August 20, 2020
Vocera Communications, the maker of hands-free communication devices for hospitals, announced yesterday that it has purchased patient-messaging technology company EASE Applications. While the two companies did not share the terms of the deal, the announcement did note that "approximately eleven" EASE employees would be issued restricted stock units equal to roughly 60,000 shares of Vocera common...
By Dave Muoio 11:06 am August 20, 2020
Pediatric behavioral care platform Brightline has brought in $20 million in Series A funding. Threshold Ventures and prior backer Oak HC/FT headed the raise, which also included Blue Shield of California, Blue Cross Blue Shield of Massachusetts, Boston Children’s Hospital, SemperVirens VC, Rock Health and City Light Capital. WHAT IT DOES The Palo Alto, California-based startup formerly known as...
By Dave Muoio 02:59 pm August 19, 2020
Somerville, Massachusetts-based virtual diabetes care company Podimetrics has added yet another $8 million to its Series B-2 funding, bringing the round's closing total to $24.6 million, the startup told MobiHealthNews. Polaris Partners, Rock Health, Norwich Ventures and Scientific Health Development, all of which had previously backed the company, contributed. Additionally, Podimetrics announced...
By Dave Muoio 01:10 pm August 19, 2020
The United States Postal Service has been at the heart of a bitter partisan divide over the last few months of COVID-19 and the U.S. election season. Prominent Democratic politicians have alleged that recent reforms and administrative changes ushered by recently appointed Postmaster General Louis DeJoy have led to widespread service delays across the country. At the same time, President Donald...
By Dave Muoio 03:03 pm August 18, 2020
23andMe announced this morning that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing. WHAT HAPPENED This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33...
By Dave Muoio 01:35 pm August 18, 2020
U.S. consumers want to understand how and why their personal health data is being used by organizations, and may change their data sharing behaviors if they believe the information is being used to improve health outcomes for themselves or others, according to recent survey from health data intelligence firm W2O. Conducted in two 1,000-person waves in September 2019 and May 2020, the poll...